Cimzia (certolizumab pegol) shows positive top-line phase 3 results in axial ... PharmaLive.com (press release) Formal drug interaction studies have not been performed with rituximab or natalizumab; however because of the nature of the adverse events seen with these combinations with TNF blocker therapy, similar toxicities may also result from the use of CIMZIA ... |
